High mitochondria content is associated with prostate cancer disease progression
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High mitochondria content is associated with prostate cancer disease progression
Authors
Keywords
MTC02, <em class=EmphasisTypeItalic >ERG</em>, Prostate cancer, Tissue microarray
Journal
Molecular Cancer
Volume 12, Issue 1, Pages 145
Publisher
Springer Nature
Online
2013-11-22
DOI
10.1186/1476-4598-12-145
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Integrative Genomic Analyses Reveal an Androgen-Driven Somatic Alteration Landscape in Early-Onset Prostate Cancer
- (2013) Joachim Weischenfeldt et al. CANCER CELL
- CHD1 Is a 5q21 Tumor Suppressor Required for ERG Rearrangement in Prostate Cancer
- (2013) L. Burkhardt et al. CANCER RESEARCH
- Prostate cancer cells metabolized-lactate inside mitochondria via ad-lactate dehydrogenase which is more active and highly expressed than in normal cells
- (2013) Lidia de Bari et al. FEBS LETTERS
- Alterations in mtDNA: A qualitative and quantitative study associated with cervical cancer development
- (2013) A. Warowicka et al. GYNECOLOGIC ONCOLOGY
- Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions
- (2013) Martina Kluth et al. MODERN PATHOLOGY
- Genomic Deletion of PTEN Is Associated with Tumor Progression and Early PSA Recurrence in ERG Fusion-Positive and Fusion-Negative Prostate Cancer
- (2012) Antje Krohn et al. AMERICAN JOURNAL OF PATHOLOGY
- Overexpression of ubiquitous mitochondrial creatine kinase (uMtCK) accelerates tumor growth by inhibiting apoptosis of breast cancer cells and is associated with a poor prognosis in breast cancer patients
- (2012) Xiao-Long Qian et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
- (2012) Patrick S. Ward et al. CANCER CELL
- The Mitochondrial and Autosomal Mutation Landscapes of Prostate Cancer
- (2012) Johan Lindberg et al. EUROPEAN UROLOGY
- Cysteine-rich secretory protein 3 overexpression is linked to a subset of PTEN-deleted ERG fusion-positive prostate cancers with early biochemical recurrence
- (2012) Katharina Grupp et al. MODERN PATHOLOGY
- PTEN/Akt Signaling Controls Mitochondrial Respiratory Capacity through 4E-BP1
- (2012) Chong Kiat Goo et al. PLoS One
- Correlation between mitochondrial TRAP-1 expression and lymph node metastasis in colorectal cancer
- (2012) Jing-Yan Gao WORLD JOURNAL OF GASTROENTEROLOGY
- TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling
- (2011) Jan C Brase et al. BMC CANCER
- Genomic profiling of mitochondrion-rich breast carcinoma: chromosomal changes may be relevant for mitochondria accumulation and tumour biology
- (2011) Felipe C. Geyer et al. BREAST CANCER RESEARCH AND TREATMENT
- ERG Status Is Unrelated to PSA Recurrence in Radically Operated Prostate Cancer in the Absence of Antihormonal Therapy
- (2011) Sarah Minner et al. CLINICAL CANCER RESEARCH
- The genomic complexity of primary human prostate cancer
- (2011) Michael F. Berger et al. NATURE
- Mitochondria in cancer: at the crossroads of life and death
- (2011) Vanessa C. Fogg et al. Chinese Journal of Cancer
- Effect of mtDNA mutation on tumor malignant degree in patients with prostate cancer
- (2010) Jian Jun Yu et al. Aging Male
- Somatic Mutations throughout the Entire Mitochondrial Genome Are Associated with Elevated PSA Levels in Prostate Cancer Patients
- (2010) Anita Kloss-Brandstätter et al. AMERICAN JOURNAL OF HUMAN GENETICS
- German cancer statistics 2004
- (2010) Jörg Haberland et al. BMC CANCER
- Integrative Genomic Profiling of Human Prostate Cancer
- (2010) Barry S. Taylor et al. CANCER CELL
- FZD4 as a Mediator of ERG Oncogene-Induced WNT Signaling and Epithelial-to-Mesenchymal Transition in Human Prostate Cancer Cells
- (2010) S. Gupta et al. CANCER RESEARCH
- Oncocytic carcinoma of the breast: frequency, morphology and follow-up
- (2010) Moira Ragazzi et al. HUMAN PATHOLOGY
- Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence
- (2010) D Hawksworth et al. PROSTATE CANCER AND PROSTATIC DISEASES
- The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes
- (2010) A. J. Levine et al. SCIENCE
- Cytoprotective Mitochondrial Chaperone TRAP-1 As a Novel Molecular Target in Localized and Metastatic Prostate Cancer
- (2009) Irwin Leav et al. AMERICAN JOURNAL OF PATHOLOGY
- Tumor suppressors and cell metabolism: a recipe for cancer growth
- (2009) R. G. Jones et al. GENES & DEVELOPMENT
- Prostate cancer regulatory networks
- (2009) Dario C. Altieri et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- ETS family transcription factors collaborate with alternative signaling pathways to induce carcinoma from adult murine prostate cells
- (2009) Y. Zong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Integration ofERGgene mapping and gene-expression profiling identifies distinct categories of human prostate cancer
- (2008) Sameer Jhavar et al. BJU INTERNATIONAL
- Cancer Cell Metabolism: Warburg and Beyond
- (2008) Peggy P. Hsu et al. CELL
- Skeletal Muscle-Specific Ablation of raptor, but Not of rictor, Causes Metabolic Changes and Results in Muscle Dystrophy
- (2008) C. Florian Bentzinger et al. Cell Metabolism
- Clinical significance of p53 alterations in surgically treated prostate cancers
- (2008) Thorsten Schlomm et al. MODERN PATHOLOGY
- Mitochondria as targets for cancer chemotherapy
- (2008) Vladimir Gogvadze et al. SEMINARS IN CANCER BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started